Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.
Clinical trial NCT00192309 · COMPLETED
Trial details
- NCT number
- NCT00192309
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Primary completion
- 2001-12-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.